Log In
Sign Up
Bacillus Calmette-Guerin (BCG), Substrain Connaught
Superficial transitional cell carcinoma (TCC) of the urinary bladder
The induction treatment comprises 6 weekly intravesical treatments, each treatment dose comprising one 81 mg vial. After a 6-week pause, another dose should be given intravesically once weekly for 1 to 3 weeks. Three weekly doses is to be given to patients who still have evidence of bladder cancer. Maintenance therapy: 1 to 3 weekly treatments at 6 months following the initiation of treatment, and then every 6 months thereafter until 36 months.
Mode of action
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us